Error in Figure

No authors listed

Published Erratum

No authors listed. JAMA Oncol. 2024.

. 2024 Jun 1;10(6):833.

doi: 10.1001/jamaoncol.2024.1062.

No abstract available

Erratum for

Noninferiority of Hypofractionated vs Conventional Postprostatectomy Radiotherapy for Genitourinary and Gastrointestinal Symptoms: The NRG-GU003 Phase 3 Randomized Clinical Trial.
Buyyounouski MK, Pugh SL, Chen RC, Mann MJ, Kudchadker RJ, Konski AA, Mian OY, Michalski JM, Vigneault E, Valicenti RK, Barkati M, Lawton CAF, Potters L, Monitto DC, Kittel JA, Schroeder TM, Hannan R, Duncan CE, Rodgers JP, Feng F, Sandler HM. Buyyounouski MK, et al. JAMA Oncol. 2024 May 1;10(5):584-591. doi: 10.1001/jamaoncol.2023.7291. JAMA Oncol. 2024. PMID: 38483412 Free PMC article. Clinical Trial.

1. Buyyounouski MK, Pugh SL, Chen RC, et al. . Noninferiority of hypofractionated vs conventional postprostatectomy radiotherapy for genitourinary and gastrointestinal symptoms: the NRG-GU003 phase 3 randomized clinical trial. JAMA Oncol. Published online March 14, 2024. doi:10.1001/jamaoncol.2023.7291 - DOI - PMC - PubMed